Related Experiment Videos
Tumor invasion, proteolysis, and angiogenesis
U P Thorgeirsson1, C K Lindsay, D W Cottam
1National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Journal of Neuro-Oncology
|January 1, 1993
Summary
This review explores proteolysis and angiogenesis in tumor invasion, focusing on proteinases like MMPs and angiogenic factors. Understanding these processes is key for developing new cancer therapies targeting tumor growth and spread.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tumor invasion involves complex interactions between tumor cells and the local microenvironment.
- Proteolytic activity and new blood vessel formation (angiogenesis) are critical for tumor growth and metastasis.
Purpose of the Study:
- To review the regulation of proteolysis and angiogenesis during tumor invasion.
- To highlight key proteinases, inhibitors, and angiogenic molecules involved in cancer progression.
Main Methods:
- Literature review of current research on proteolysis and angiogenesis in tumor invasion.
- Focus on plasminogen activator (PA)/plasmin and matrix metalloproteinases (MMP) systems, including TIMP-1 and TIMP-2.
- Discussion of key angiogenic molecules and their inhibitors.
Main Results:
- Proteolysis, mediated by PAs and MMPs, facilitates tissue breakdown during invasion.
- Tumor cells interact with endothelial cells and stimulate angiogenesis via specific molecules.
- Numerous synthetic and natural angiogenesis inhibitors have been identified.
Conclusions:
- Understanding the regulation of proteolysis and angiogenesis is crucial for brain tumor research.
- Targeting angiogenic molecules and tumor vasculature presents a promising strategy for future cancer therapeutics.